Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.070
-0.030 (-2.73%)
At close: Aug 1, 2025, 4:00 PM
1.072
+0.002 (0.15%)
After-hours: Aug 1, 2025, 7:16 PM EDT

Smartsheet Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1231883699805,5877,933
Upgrade
Market Cap Growth
-89.16%-49.04%-62.39%-82.45%-29.57%436.26%
Upgrade
Enterprise Value
-34-101245865,0187,530
Upgrade
Last Close Price
1.071.653.7410.0958.5190.93
Upgrade
PS Ratio
9.4713.795.8010.18100.05252.37
Upgrade
PB Ratio
0.430.591.002.038.2320.64
Upgrade
P/TBV Ratio
0.430.591.002.038.2320.64
Upgrade
EV/Sales Ratio
--1.956.0989.85239.54
Upgrade
Debt / Equity Ratio
0.290.270.280.230.170.25
Upgrade
Asset Turnover
0.030.030.110.120.070.07
Upgrade
Quick Ratio
8.707.398.134.177.705.73
Upgrade
Current Ratio
8.827.588.484.407.795.78
Upgrade
Return on Equity (ROE)
-49.23%-54.21%-37.76%-48.46%-39.91%-55.11%
Upgrade
Return on Assets (ROA)
-23.97%-25.81%-19.65%-23.69%-17.57%-17.31%
Upgrade
Return on Capital (ROIC)
-25.80%-27.90%-22.36%-27.79%-21.27%-21.25%
Upgrade
Earnings Yield
-143.39%-99.11%-43.64%-28.73%-3.80%-2.19%
Upgrade
FCF Yield
-102.05%-65.77%-37.53%-28.94%-3.82%-0.56%
Upgrade
Buyback Yield / Dilution
-18.99%-15.52%-1.64%-2.19%-15.00%-20.82%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q